Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 89 for your search:
Cancer Type/Condition:  Multiple myeloma / Plasma cell neoplasm
Trial Type:  Supportive care
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H0901329, NCT01189409

2.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: Par 06-0045, NCT01313247

3.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: NMSG 22/14, 2014-001121-32, NCT02286830

4.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 months to 21 years
Sponsor: Other
Protocol IDs: #1R01FD003410-01, R01 FD003410-01-A1, NCT00999713

5.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 001/14, NCT02085694

6.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: MSC-CY-Russia, NCT02270307

7.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040212, UCLA-0412042-01, AMGEN-20040212, NCT00109031

8.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 15 to 79
Sponsor: Other
Protocol IDs: C-SHOT 0402, NCT00137787

9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EmNa (2001-004956-38), EudraCT-No: 2004-004956-38, NCT00571168

10.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PB-PG-0107-11134, ISRCTN04119516, NCT00678405

11.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-0808, NCI-2012-01673, NCT00761618

12.

Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: Version 1.1, NCT00872352

13.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EA4/031/09, NCT00884364

14.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VORI911, NCT00893555

15.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Esperanz-001, M010-025, NCT01136005

16.

Phase: Phase III
Type: Behavioral study, Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 176-25/kmo, NCT01035203

17.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: P081226, NCT01208818

18.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P01CA018029, P30CA015704, NCT01231412

19.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 20120673, NCT01237639

20.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: V212-011, CTRI/2012/05/002673, NCT01254630

21.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000696704, CRUK-KPS-2008-01, EU-21012, EUDRACT-2007-002080-27, ISRCTN-49116945, NCT01316744

22.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: UAMS 2009-50, NCT01314625

23.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GWCA0999, 2009-016529-32, NCT01337089

24.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: P 1201, NCT01797952

25.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RATIOMTD-010810, 2010-024092-39, EC10-133, NCT01836328
1     
New Search